Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,691.64 -1,740.57 (-2.79%) CMC Crypto 200
1,259.22 -98.79 (-7.27%)
CANbridge Pharmaceuticals Inc. (1228.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 03:59PM HKT
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 150.72M |
| Enterprise value | 155.60M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.33 |
| Price/book (mrq) | 1.46 |
| Enterprise value/revenue | 1.51 |
| Enterprise value/EBITDA | -0.42 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.72 |
| 52-week change 3 | -77.81% |
| S&P500 52-week change 3 | 26.43% |
| 52-week high 3 | 2.030 |
| 52-week low 3 | 0.250 |
| 50-day moving average 3 | 0.349 |
| 200-day moving average 3 | 0.935 |
Share statistics
| Avg vol (3-month) 3 | 47.46k |
| Avg vol (10-day) 3 | 145.6k |
| Shares outstanding 5 | 424.56M |
| Implied shares outstanding 6 | 424.56M |
| Float 8 | 279.41M |
| % held by insiders 1 | 10.00% |
| % held by institutions 1 | 30.10% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -273.70% |
Management effectiveness
| Return on assets (ttm) | -41.75% |
| Return on equity (ttm) | -281.91% |
Income statement
| Revenue (ttm) | 102.87M |
| Revenue per share (ttm) | 0.24 |
| Quarterly revenue growth (yoy) | 35.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -357.42M |
| Net income avi to common (ttm) | -378.84M |
| Diluted EPS (ttm) | -0.960 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 137.49M |
| Total cash per share (mrq) | 0.32 |
| Total debt (mrq) | 141.93M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.64 |
| Book value per share (mrq) | -0.09 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.